Difference between revisions of "Pemmaraju N, et al. Blood (2016) cited as Ref 558 in DOI: 10.1038/s41392-020-0110-5 (Q9821)"
Jump to navigation
Jump to search
(Created claim: DOI Identifier (P138): 10.1182/blood.V128.22.342.342, #quickstatements; #temporary_batch_1590000649558) |
(Created claim: Publication Date (P100): 2016, #quickstatements; #temporary_batch_1590002823654) |
||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2016
| ||||||||||||||
| Property / Publication Date: 2016 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Revision as of 19:47, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Pemmaraju N, et al. Blood (2016) cited as Ref 558 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Pemmaraju N
0 references
2016
0 references
